Bruce D Hammock

Eicosis, LLC

NIH Rank #1896
  • R01 Holder
  • Top 10% Funded
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#1,896
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.6M across 4 grants · National rank #1896.

Top grants by award amount

Bruce D Hammock's NIH grant portfolio, ranked by award amount.

  • 4UH3DA048767-03UH3
    Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
    $2.1M
    award amount
  • 5R35ES030443-06R35
    Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases
    $756.8K
    award amount
  • 5R01EY035222-02R01
    Soluble epoxide hydrolase and epoxide fatty acid involvement in corneal injury after ammonia exposure: Mechanisms of injury and potential therapeutics using sEH inhibitors and biostable EpFA mimics.
    $470.6K
    award amount
  • 3R35ES030443-06S1R35
    Supplement for bioactive lipids as effectors and indicators of the deleterious effects of human health
    $269.8K
    award amount

Affiliations

Institutions that have administered grants for Bruce D Hammock.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Eicosis, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1896
  6. 2024
    Entered Top 25% Nationally
    Ranked #1896
  7. 2024
    Entered Top 10% Nationally
    Ranked #1896
  8. 2024
    Multi-Institutional Research
    Awards at 3 institutions

Related investigators

Other NIH-funded PIs frequently associated with Bruce D Hammock.